Literature DB >> 21337671

Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients.

James H Yeung1, Karen J Goodman, Richard N Fedorak.   

Abstract

BACKGROUND: Immunosuppressive agents, used commonly to treat inflammatory bowel disease (IBD), are associated with an increased risk of infections, including those preventable by immunization. This study aimed to describe physician and patient values and knowledge regarding immunization and immunization histories.
METHODS: In all, 167 IBD patients and 43 gastroenterologists completed mail-out questionnaires. Patients were asked 15 questions about their immunization histories and attitudes towards immunization. Gastroenterologists were asked nine questions about immunization for the immunocompromised host.
RESULTS: The questionnaire return rate was 45.7% (43/94) for gastroenterologists and 25.2% (167/661) for patients. Only 14.3% (6/42) of gastroenterologists reported taking an immunization history from most or all of their patients. Only 5.4% (9/167) of patients recalled being asked by their gastroenterologist whether their immunizations were up to date, and just 0.6% (1/164) recalled being asked for a detailed immunization history. Overall, 21.7% (35/161) of patients had refused to be immunized in the past; 18.6% (8/43) of gastroenterologists did not know if up-to-date immunizations were important prior to starting immunosuppressive therapy. Of note, 23.1% (9/39) of gastroenterologists and 46.7% (35/161) of patients did not know whether live vaccines should be avoided by those in the immunosuppressed state, and 42.9% (18/43) of gastroenterologists acknowledged they did not know which specific immunizations should be avoided for immunosuppressed patients.
CONCLUSIONS: Gastroenterologists have limited knowledge of their IBD patients' immunization status and rarely take an adequate immunization history. Substantial proportions of IBD patients and gastroenterologists lack adequate knowledge of established immunization guidelines prior to initiation of immunosuppressive therapy.
Copyright © 2011 Crohn's & Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21337671     DOI: 10.1002/ibd.21668

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  34 in total

1.  Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.

Authors:  Mustafa Erhan Altunöz; Ebubekir Senateş; Atakan Yeşil; Turan Calhan; Ayşe Oya Kurdaş Ovünç
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis.

Authors:  Douglas L Nguyen; Emily T Nguyen; Matthew L Bechtold
Journal:  Dig Dis Sci       Date:  2015-03-22       Impact factor: 3.199

Review 3.  A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors:  Benjamin Click; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

Review 4.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

Review 5.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Disseminated Varicella Zoster Virus Infection with Encephalitis in a UC Patient Receiving Infliximab.

Authors:  Saleh M Elwir; Christopher C Shaffer; Susan W Arvan; Ethan F Kuperman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

Review 7.  Vaccination in the Elderly and IBD.

Authors:  Anthony J Choi; Preston Atteberry; Dana J Lukin
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

8.  Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.

Authors:  Hung-Viet Pham; Imran Hasan; Natalia Udaltsova; Kathy Pham; Oren Abramson; Mary Anne Armstrong; Debbie Postlethwaite; Dan Li
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

9.  Travel health and pretravel preparation in the patient with inflammatory bowel disease.

Authors:  Kay Greveson; Thomas Shepherd; John P Mulligan; Mark Hamilton; Sue Woodward; Christine Norton; Charles Murray
Journal:  Frontline Gastroenterol       Date:  2015-04-22

Review 10.  Efficacy of the vaccination in inflammatory bowel disease.

Authors:  Elisa Carrera; Rebeca Manzano; Elena Garrido
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.